Senores Pharmaceuticals lists with 52% premium on the BSE
Senores Pharmaceuticals has debuted at Rs 593.70 on the BSE, up by 202.7 points or 51.84% from its issue price of Rs 391.00.
The scrip is currently trading at Rs 569.25, up by 178.25 points or 45.59% from its issue price.
It has touched a high and low of Rs 609.00 and Rs 566.85 respectively. So far 6.74 lakh shares were traded on the counter.
The offering, which was open for subscription between December 20, 2024 and December 24, 2024 was subscribed around 93 times. The issue price was fixed at Rs 391.00 per share i.e. at upper end of price band of Rs 372-391apiece.
Senores Pharmaceuticals is global research driven pharmaceutical company engaged in developing and manufacturing a wide range of generic pharmaceutical products in the B2B segment predominantly for the Regulated Markets across various therapeutic areas and dosage forms.
